Innovative Engagement Tools BBK's recent launch of TCN Engage demonstrates its commitment to enhancing patient engagement and visit support services, presenting an opportunity to offer complementary solutions that further improve trial retention and participant experience.

Growth Through Acquisition Integrating with Publicis Health since 2022 positions BBK within a broader health marketing ecosystem, enabling cross-selling of integrated advertising and patient recruitment services to pharmaceutical companies seeking comprehensive clinical trial solutions.

Successful Industry Recognition Winning the accolade for its Clinical Cuisine service as an innovative product in 2022 highlights BBK’s innovative capacity, opening sales opportunities for partners interested in cutting-edge patient support and trial experience enhancements.

Diverse Service Portfolio BBK’s full spectrum of patient recruitment, engagement, and concierge services, backed by patented technology, allows for upselling tailored solutions that can address specific clinical trial challenges faced by pharmaceutical sponsors.

Strong Market Position With estimated revenues of 10 to 25 million USD and a specialized team, BBK represents a lucrative target for strategic partnerships and licensing deals, especially with companies aiming to improve diversity, equity, and inclusion in clinical research.